Anemia de células falciformes en pediatría: revisión de la literatura

La anemia falciforme es una hemoglobinopatía estructural de origen genético, se caracteriza por la presencia de hemoglobina falciforme. La hemoglobina anormales inestable, tiende a polimerizarse y puede ocluirla microcirculación, produciendo manifestaciones multisistémicas tanto agudas como crónicas...

Full description

Autores:: Tirado Pérez, Irina Suley
Zárate Vergara, Andrea Carolina

Tipo de recurso:: Article of journal

Fecha de publicación:: 2018

Institución:: Universidad Autónoma de Bucaramanga - UNAB

Repositorio:: Repositorio UNAB

Idioma:: spa

id	UNAB2_4d3bd6e7dc1e05382b4efeb1b6fcdb5b
oai_identifier_str	oai:repository.unab.edu.co:20.500.12749/9962
network_acronym_str	UNAB2
network_name_str	Repositorio UNAB
repository_id_str
dc.title.none.fl_str_mv	Anemia de células falciformes en pediatría: revisión de la literatura
dc.title.translated.eng.fl_str_mv	Sickle cell anemia in pediatrics: literature review
dc.title.translated.port.fl_str_mv	Anemia falciforme em pediatria: Revisão da literatura
title	Anemia de células falciformes en pediatría: revisión de la literatura
spellingShingle	Anemia de células falciformes en pediatría: revisión de la literatura Anemia, Hemolytic Anemia, Sickle Cell Hemoglobin, Sickle Pediatrics Hemoglobin SC Disease Ciencias médicas Ciencias de la salud Anemia hemolítica Anemia de células falciformes Hemoglobina falciforme Pediatría Enfermedad de la hemoglobina SC
title_short	Anemia de células falciformes en pediatría: revisión de la literatura
title_full	Anemia de células falciformes en pediatría: revisión de la literatura
title_fullStr	Anemia de células falciformes en pediatría: revisión de la literatura
title_full_unstemmed	Anemia de células falciformes en pediatría: revisión de la literatura
title_sort	Anemia de células falciformes en pediatría: revisión de la literatura
dc.creator.fl_str_mv	Tirado Pérez, Irina Suley Zárate Vergara, Andrea Carolina
dc.contributor.author.spa.fl_str_mv	Tirado Pérez, Irina Suley Zárate Vergara, Andrea Carolina
dc.contributor.cvlac.none.fl_str_mv	Tirado Pérez, Irina Suley [0001553010] Zárate Vergara, Andrea Carolina [0001535059]
dc.contributor.googlescholar.none.fl_str_mv	Zárate Vergara, Andrea Carolina [xhlO9JQAAAAJ&hl=es&oi=ao]
dc.contributor.orcid.none.fl_str_mv	Tirado Pérez, Irina Suley [0000-0002-9995-3287] Zárate Vergara, Andrea Carolina [0000-0001-8716-7097]
dc.subject.keywords.eng.fl_str_mv	Anemia, Hemolytic Anemia, Sickle Cell Hemoglobin, Sickle Pediatrics Hemoglobin SC Disease
topic	Anemia, Hemolytic Anemia, Sickle Cell Hemoglobin, Sickle Pediatrics Hemoglobin SC Disease Ciencias médicas Ciencias de la salud Anemia hemolítica Anemia de células falciformes Hemoglobina falciforme Pediatría Enfermedad de la hemoglobina SC
dc.subject.lemb.none.fl_str_mv	Ciencias médicas Ciencias de la salud
dc.subject.proposal.none.fl_str_mv	Anemia hemolítica Anemia de células falciformes Hemoglobina falciforme Pediatría Enfermedad de la hemoglobina SC
description	La anemia falciforme es una hemoglobinopatía estructural de origen genético, se caracteriza por la presencia de hemoglobina falciforme. La hemoglobina anormales inestable, tiende a polimerizarse y puede ocluirla microcirculación, produciendo manifestaciones multisistémicas tanto agudas como crónicas relacionándose con mayor riesgo de contraer infecciones. Objetivo: Describir la información del tema expuesto resaltando los aspectos más relevantes como diagnóstico y tratamiento. Metodología: Se efectuó una revisión bibliográfica con búsqueda electrónica en las siguientes bases de datos: PubMed, MEDLINE, Medscape, Scopus; y se incluyó diferentes tipos de artículo (artículos originales, revisiones de temas y guías de manejo) que abordaran la anemia de células falciformes en pediatría. Resultados: Se obtuvo una revisión de 22 artículos, donde se describe el tema de anemia de células falciformes, pautas y tratamientos basados en el manejo y control de los síntomas; se evidencia que el uso de ecografía doppler transcraneal y las transfusiones demostraron ser estrategias preventivas o de tratamiento eficaces para las complicaciones relacionadas con esta patología en los niños. Conclusiones: En Colombia, la prevalencia de la patología no se encuentra establecida. Por otra parte, las principales manifestaciones se relacionan con complicaciones de vaso-oclusión en los diferentes órganos y la asplenia funcional, la cual predispone a cuadros infecciosos. [Tirado-Pérez IS, Zárate Vergara AC. Anemia de células falciformes en pediatría: Revisión de la literatura. Revisión de tema. MedUNAB2017-2018; 20(3): 374-382]
publishDate	2018
dc.date.issued.none.fl_str_mv	2018-07-06
dc.date.accessioned.none.fl_str_mv	2020-10-27T14:19:26Z
dc.date.available.none.fl_str_mv	2020-10-27T14:19:26Z
dc.type.coar.fl_str_mv	http://purl.org/coar/resource_type/c_2df8fbb1
dc.type.coarversion.fl_str_mv	http://purl.org/coar/version/c_970fb48d4fbd8a85
dc.type.driver.none.fl_str_mv	info:eu-repo/semantics/article
dc.type.local.spa.fl_str_mv	Artículo
dc.type.coar.none.fl_str_mv	http://purl.org/coar/resource_type/c_6501
dc.type.redcol.none.fl_str_mv	http://purl.org/redcol/resource_type/ART
format	http://purl.org/coar/resource_type/c_6501
dc.identifier.issn.none.fl_str_mv	2382-4603 0123-7047
dc.identifier.uri.none.fl_str_mv	http://hdl.handle.net/20.500.12749/9962
dc.identifier.instname.spa.fl_str_mv	instname:Universidad Autónoma de Bucaramanga UNAB
dc.identifier.repourl.none.fl_str_mv	repourl:https://repository.unab.edu.co
dc.identifier.doi.none.fl_str_mv	10.29375/01237047.2378
identifier_str_mv	2382-4603 0123-7047 instname:Universidad Autónoma de Bucaramanga UNAB repourl:https://repository.unab.edu.co 10.29375/01237047.2378
url	http://hdl.handle.net/20.500.12749/9962
dc.language.iso.spa.fl_str_mv	spa
language	spa
dc.relation.none.fl_str_mv	https://revistas.unab.edu.co/index.php/medunab/article/view/2378/2862 /ref/Maakaron J, Taher A. Sickle Cell Anemia. Medscape article. [Internet]. 2015. [Updated: Oct 15, 2015]. Disponible en: http://emedicine.medscape.com/article/205926-overview 2. Quintero M, Jiménez A. Anemia De Células Falciformes. Revista Gastrohnup. 2012; 14(2):Sup1:S27-S35. 3. Ayala A, González H, David G. Anemia de células falciformes: una revisión. Salud Uninorte. 2016; 32(3):513-527. 4. Kavanagh P, Sprinz P, Vinci S, Bauchner H, Wang C. Management of Children With Sickle Cell Disease: A Comprehensive Review of the Literature. Pediatrics. 2011; 128(6):1552-1574. 5. Lemanek K, Ranalli M, Lukens C. A randomized controlled trial of massage therapy in children with sickle cell disease. J Pediatr Psychol. 2009; 34(10):1091–1096. 6. McClellan C, Schatz J, Puffer E, Sanchez C, Stancil M, Roberts C. Use of handheld wireless technology for a home-based sickle cell pain management protocol. J Pediatr Psychol. 2009; 34(5):564–573. 7. Nolan V, Zhang Y, Lash T, Sebastiani P, Steinberg M. Association between wind speed and the occurrence of sickle cell acute painful episodes: results of a casecrossover study. Br J Haematol. 2008; 143(3):433–8. 8. Meier E, Miller J. Sickle cell disease in children. Drugs. 2012; 72(7):895-906. 9. Sparkenbaugh E, Pawlinski R. Prothrombotic aspects of sickle cell disease. J Thromb Haemost. 2017; 15(7):1307–16. 10. Cervera Á, Cela E. Anemia falciforme. Manejo en Atención Primaria. Rev Pediatr Aten Primaria. 2007; 9(36):649-68. 11. Driscoll M, Hurlet A, Styles L, Mckie V, Files B, et al. Stroke risk in siblings with sickle cell anemia. Blood. 2003; 101(6):2401-2404. 12. Yazdanbakhsh K, Shaz B, Hillyer C. Immune regulation of sickle cell alloimmunization. ISBT Science Series. 2017; 12(1):248–253. Disponible en: https://doi.org/10.1111/voxs.12296. 13. National Heart, Lung, and Blood Institute. Management and therapy of sickle cell disease. 4ed. Bethesda. [Internet]. 2002. [Revisado el: Oct 15, 2015]. Disponible en: https://www.nhlbi.nih.gov/files/docs/guidelines/sc_mngt.pdf 14. American Academy of Pediatrics, Section on Hematology/Oncology and Committee on Genetics. Health supervision for children with sickle cell disease. Pediatrics. 2002; 109(3):526-35. 15. Adams R, McKie V, Hsu L, Files B, Vichinsky E, et al. Prevention of a First Stroke by Transfusions in Children with Sickle Cell Anemia and Abnormal Results on Transcranial Doppler Ultrasonography. N Engl J Med. 1998; 339:5-11. 16. Yawn B, Buchanan G, Afenyi-Annan A, et al. Management of Sickle Cell Disease: Summary of the 2014 Evidence-Based Report by Expert Panel Members. JAMA. 2014; 312(10):1033-1048. Disponible en: https://doi.org/10.1001/Jama.2014.10517. 17. Adams R, Brambilla D, Granger S, Gallagher D, Vichinsky E, et al. Stroke and Conversion To High Risk In Children Screened With Transcranial Doppler Ultrasound During The STOP Study. Blood. 2004; 103(10):3689-3694. 18. Vichinsky E, Neumayr L, Earles A, Williams R, Lennette E, et al. Causes and outcomes of the acute chest syndrome in sickle cell disease. N Engl J Med. 2000; 342(25):1855–1865. 19. Morris C, Vichinsky E, Styles L. Clinician assessment for acute chest syndrome in febrile patients with sickle cell disease: is it accurate enough?. Ann Emerg Med. 1999; 34(1):64–69. 20. Smith K, Zhao H, Hodinka RL, et al. Epidemiology of human parvovirus B19 in children with sickle cell disease. Blood. 2004; 103(2):422–427. 21. Gil K, Carson J, Porter L, Ready J, Valrie C, et al. Daily stress and mood and their association with pain, health-care use, and school activity in adolescents with sickle cell disease. J Pediatr Psychol. 2003; 28(5):363–373. 22. Jacob E, Miaskowski C, Savedra M, Beyer J, Treadwell M, Styles L. Management of vaso-occlusive pain in children with sickle cell disease. J Pediatr Hematol Oncol. 2003; 25(4):307–311.
dc.relation.uri.none.fl_str_mv	https://revistas.unab.edu.co/index.php/medunab/article/view/2378
dc.relation.references.none.fl_str_mv	Maakaron J, Taher A. Sickle Cell Anemia. Medscape article.[Internet].2015.[Updated:Oct15,2015]. Disponible http://emedicine.medscape.com/article/205926-overview Quintero M, Jiménez A. Anemia De Células Falciformes. Revista Gastrohnup. 2012; 14(2):Sup1:S27-S35 AyalaA,GonzálezH,DavidG.Anemiadecélulas falciformes:unarevisión.SaludUninorte.2016; 32(3):513-527 Kavanagh P, Sprinz P, Vinci S, Bauchner H, Wang C. Management of Children With Sickle Cell Disease: A Comprehensive Review of th eLiterature.Pediatrics. 2011; 128(6):1552-1574 LemanekK,RanalliM,LukensC.Arandomized controlled trial of massage therapy in children with sickle cell disease. J Pediatr Psychol. 2009; 34(10):1091–1096 McClellan C, Schatz J, Puffer E, Sanchez C, Stancil M, Roberts C. Use of handheld wireless technology for a home-based sickle cell pain management protocol. J Pediatr Psychol. 2009; 34(5):564–573 Nolan V, Zhang Y, Lash T, Sebastiani P, Steinberg M. Association between wind speed and the occurrence of sicklecellacutepainfulepisodes:resultsofa casecrossover study. Br J Haematol. 2008; 143(3):433–8 Meier E, Miller J. Sickle cell disease in children. Drugs. 2012; 72(7):895-906 Sparkenbaugh E, Pawlinski R. Prothrombotic aspects of sicklecelldisease.JThrombHaemost.2017; 15(7):1307–16 CerveraÁ,CelaE.Anemiafalciforme.Manejoen Atención Primaria. Rev Pediatr Aten Primaria. 2007; 9(36):649-68 Driscoll M, Hurlet A, Styles L, Mckie V, Files B, et al. Stroke risk in siblings with sickle cell anemia. Blood. 2003; 101(6):2401-2404 Yazdanbakhsh K, Shaz B, Hillyer C. Immune regulation of sickle cell alloimmunization. ISBT Science Series. 2017; 12(1):248–253.Disponibleen:https://doi.org/10.1111/ voxs.12296 National Heart, Lung, and Blood Institute. Management andtherapyofsicklecelldisease.4ed.Bethesda. [Internet]. 2002. [Revisado el: Oct 15, 2015]. Disponible en: https://www.nhlbi.nih.gov/files/docs/guidelines/sc_mngt.pd AmericanAcademyofPediatrics,Sectionon Hematology/OncologyandCommitteeonGenetics. Health supervision for children with sickle cell disease. Pediatrics. 2002; 109(3):526-35 Adams R, McKie V, Hsu L, Files B, Vichinsky E, et al. Prevention of a First Stroke by Transfusions in Children withSickleCellAnemiaandAbnormalResultson Transcranial Doppler Ultrasonography. N Engl J Med. 1998; 339:5-1 Yawn B, Buchanan G, Afenyi-Annan A, et al. Management of Sickle Cell Disease: Summary of the 2014 Evidence-Based Report by Expert Panel Members. JAMA. 2014; 312(10):1033-1048.Disponibleen:https://doi.org/ 10.1001/Jama.2014.10517 Adams R, Brambilla D, Granger S, Gallagher D, Vichinsky E, et al. Stroke and Conversion To High Risk In Children Screened With Transcranial Doppler Ultrasound During The STOP Study. Blood. 2004; 103(10):3689-3694 Vichinsky E, Neumayr L, Earles A, Williams R, Lennette E, et al. Causes and outcomes of the acute chest syndrome insicklecelldisease.NEnglJMed.2000; 342(25):1855–1865 Morris C, Vichinsky E, Styles L. Clinician assessment for acute chest syndrome in febrile patients with sickle cell disease: is it accurate enough?. Ann Emerg Med. 1999; 34(1):64–69 Smith K, Zhao H, Hodinka RL, et al. Epidemiology of human parvovirus B19 in children with sickle cell disease. Blood. 2004; 103(2):422–427 Gil K, Carson J, Porter L, Ready J, Valrie C, et al. Daily stress and mood and their association with pain, health-care use, and school activity in adolescents with sickle cell disease. J Pediatr Psychol. 2003; 28(5):363–373 Jacob E, Miaskowski C, Savedra M, Beyer J, Treadwell M, Styles L. Management of vaso-occlusivepainin children with sickle cell disease. J Pediatr Hematol Oncol. 2003; 25(4):307–311
dc.rights.coar.fl_str_mv	http://purl.org/coar/access_right/c_abf2
dc.rights.uri.none.fl_str_mv	http://creativecommons.org/licenses/by-nc-nd/2.5/co/
dc.rights.creativecommons.*.fl_str_mv	Atribución-NoComercial-SinDerivadas 2.5 Colombia
rights_invalid_str_mv	http://creativecommons.org/licenses/by-nc-nd/2.5/co/ Atribución-NoComercial-SinDerivadas 2.5 Colombia http://purl.org/coar/access_right/c_abf2
dc.format.mimetype.spa.fl_str_mv	application/pdf
dc.publisher.none.fl_str_mv	Universidad Autónoma de Bucaramanga UNAB
dc.publisher.faculty.none.fl_str_mv	Facultad Ciencias de la Salud
dc.publisher.program.none.fl_str_mv	Pregrado Medicina
publisher.none.fl_str_mv	Universidad Autónoma de Bucaramanga UNAB
dc.source.none.fl_str_mv	MedUNAB; Vol. 20 Núm. 3 (2018): Diciembre - Marzo de 2018: Educación, Tabaquismo, Accidente Ofídico; 374-382
institution	Universidad Autónoma de Bucaramanga - UNAB
bitstream.url.fl_str_mv	https://repository.unab.edu.co/bitstream/20.500.12749/9962/1/2018_Anemia_de_c%c3%a9lulas_falciformes_en_pediatr%c3%ada.pdf https://repository.unab.edu.co/bitstream/20.500.12749/9962/2/2018_Anemia_de_c%c3%a9lulas_falciformes_en_pediatr%c3%ada.pdf.jpg
bitstream.checksum.fl_str_mv	08a3ba7af4183115dcccb5ec13b4bd2e 3d16d223c2431d65fee752da3780ab8d
bitstream.checksumAlgorithm.fl_str_mv	MD5 MD5
repository.name.fl_str_mv	Repositorio Institucional \| Universidad Autónoma de Bucaramanga - UNAB
repository.mail.fl_str_mv	repositorio@unab.edu.co
_version_	1828219834931871744
spelling	Tirado Pérez, Irina Suley1b8cc733-f87c-439d-b756-72d4c5e71b71-1Zárate Vergara, Andrea Carolina48a31335-e740-4bb9-ba70-a9f7e8f3c9e3-1Tirado Pérez, Irina Suley [0001553010]Zárate Vergara, Andrea Carolina [0001535059]Zárate Vergara, Andrea Carolina [xhlO9JQAAAAJ&hl=es&oi=ao]Tirado Pérez, Irina Suley [0000-0002-9995-3287]Zárate Vergara, Andrea Carolina [0000-0001-8716-7097]2020-10-27T14:19:26Z2020-10-27T14:19:26Z2018-07-062382-46030123-7047http://hdl.handle.net/20.500.12749/9962instname:Universidad Autónoma de Bucaramanga UNABrepourl:https://repository.unab.edu.co10.29375/01237047.2378La anemia falciforme es una hemoglobinopatía estructural de origen genético, se caracteriza por la presencia de hemoglobina falciforme. La hemoglobina anormales inestable, tiende a polimerizarse y puede ocluirla microcirculación, produciendo manifestaciones multisistémicas tanto agudas como crónicas relacionándose con mayor riesgo de contraer infecciones. Objetivo: Describir la información del tema expuesto resaltando los aspectos más relevantes como diagnóstico y tratamiento. Metodología: Se efectuó una revisión bibliográfica con búsqueda electrónica en las siguientes bases de datos: PubMed, MEDLINE, Medscape, Scopus; y se incluyó diferentes tipos de artículo (artículos originales, revisiones de temas y guías de manejo) que abordaran la anemia de células falciformes en pediatría. Resultados: Se obtuvo una revisión de 22 artículos, donde se describe el tema de anemia de células falciformes, pautas y tratamientos basados en el manejo y control de los síntomas; se evidencia que el uso de ecografía doppler transcraneal y las transfusiones demostraron ser estrategias preventivas o de tratamiento eficaces para las complicaciones relacionadas con esta patología en los niños. Conclusiones: En Colombia, la prevalencia de la patología no se encuentra establecida. Por otra parte, las principales manifestaciones se relacionan con complicaciones de vaso-oclusión en los diferentes órganos y la asplenia funcional, la cual predispone a cuadros infecciosos. [Tirado-Pérez IS, Zárate Vergara AC. Anemia de células falciformes en pediatría: Revisión de la literatura. Revisión de tema. MedUNAB2017-2018; 20(3): 374-382]Sickle cell anemia is a structural hemoglobinopathy of genetic origin, characterized by the presence of sickle hemoglobin. The unstable abnormal hemoglobin tends to polymerize and can occlude the microcirculation, producing both acute and chronic multisystemic manifestations associated with a higher risk of contracting infections. Objective: Describe the information on the exposed topic highlighting the most relevant aspects such as diagnosis and treatment. Methodology: A bibliographic review was carried out with an electronic search in the following databases: PubMed, MEDLINE, Medscape, Scopus; and different types of articles were included (original articles, topic reviews and management guides) that addressed sickle cell anemia in pediatrics. Results: A review of 22 articles was obtained, which describes the topic of sickle cell anemia, guidelines and treatments based on the management and control of symptoms; it is evidenced that the use of transcranial Doppler ultrasound and transfusions proved to be effective preventive or treatment strategies for complications related to this pathology in children. Conclusions: In Colombia, the prevalence of the pathology has not been established. On the other hand, the main manifestations are related to vaso-occlusion complications in the different organs and functional asplenia, which predisposes to infectious conditions. [Tirado-Pérez IS, Zárate Vergara AC. Sickle Cell Anemia in Pediatrics: Review of the Literature. Topic review. MedUNAB2017-2018; 20 (3): 374-382]application/pdfspaUniversidad Autónoma de Bucaramanga UNABFacultad Ciencias de la SaludPregrado Medicinahttps://revistas.unab.edu.co/index.php/medunab/article/view/2378/2862/ref/Maakaron J, Taher A. Sickle Cell Anemia. Medscape article. [Internet]. 2015. [Updated: Oct 15, 2015]. Disponible en: http://emedicine.medscape.com/article/205926-overview 2. Quintero M, Jiménez A. Anemia De Células Falciformes. Revista Gastrohnup. 2012; 14(2):Sup1:S27-S35. 3. Ayala A, González H, David G. Anemia de células falciformes: una revisión. Salud Uninorte. 2016; 32(3):513-527. 4. Kavanagh P, Sprinz P, Vinci S, Bauchner H, Wang C. Management of Children With Sickle Cell Disease: A Comprehensive Review of the Literature. Pediatrics. 2011; 128(6):1552-1574. 5. Lemanek K, Ranalli M, Lukens C. A randomized controlled trial of massage therapy in children with sickle cell disease. J Pediatr Psychol. 2009; 34(10):1091–1096. 6. McClellan C, Schatz J, Puffer E, Sanchez C, Stancil M, Roberts C. Use of handheld wireless technology for a home-based sickle cell pain management protocol. J Pediatr Psychol. 2009; 34(5):564–573. 7. Nolan V, Zhang Y, Lash T, Sebastiani P, Steinberg M. Association between wind speed and the occurrence of sickle cell acute painful episodes: results of a casecrossover study. Br J Haematol. 2008; 143(3):433–8. 8. Meier E, Miller J. Sickle cell disease in children. Drugs. 2012; 72(7):895-906. 9. Sparkenbaugh E, Pawlinski R. Prothrombotic aspects of sickle cell disease. J Thromb Haemost. 2017; 15(7):1307–16. 10. Cervera Á, Cela E. Anemia falciforme. Manejo en Atención Primaria. Rev Pediatr Aten Primaria. 2007; 9(36):649-68. 11. Driscoll M, Hurlet A, Styles L, Mckie V, Files B, et al. Stroke risk in siblings with sickle cell anemia. Blood. 2003; 101(6):2401-2404. 12. Yazdanbakhsh K, Shaz B, Hillyer C. Immune regulation of sickle cell alloimmunization. ISBT Science Series. 2017; 12(1):248–253. Disponible en: https://doi.org/10.1111/voxs.12296. 13. National Heart, Lung, and Blood Institute. Management and therapy of sickle cell disease. 4ed. Bethesda. [Internet]. 2002. [Revisado el: Oct 15, 2015]. Disponible en: https://www.nhlbi.nih.gov/files/docs/guidelines/sc_mngt.pdf 14. American Academy of Pediatrics, Section on Hematology/Oncology and Committee on Genetics. Health supervision for children with sickle cell disease. Pediatrics. 2002; 109(3):526-35. 15. Adams R, McKie V, Hsu L, Files B, Vichinsky E, et al. Prevention of a First Stroke by Transfusions in Children with Sickle Cell Anemia and Abnormal Results on Transcranial Doppler Ultrasonography. N Engl J Med. 1998; 339:5-11. 16. Yawn B, Buchanan G, Afenyi-Annan A, et al. Management of Sickle Cell Disease: Summary of the 2014 Evidence-Based Report by Expert Panel Members. JAMA. 2014; 312(10):1033-1048. Disponible en: https://doi.org/10.1001/Jama.2014.10517. 17. Adams R, Brambilla D, Granger S, Gallagher D, Vichinsky E, et al. Stroke and Conversion To High Risk In Children Screened With Transcranial Doppler Ultrasound During The STOP Study. Blood. 2004; 103(10):3689-3694. 18. Vichinsky E, Neumayr L, Earles A, Williams R, Lennette E, et al. Causes and outcomes of the acute chest syndrome in sickle cell disease. N Engl J Med. 2000; 342(25):1855–1865. 19. Morris C, Vichinsky E, Styles L. Clinician assessment for acute chest syndrome in febrile patients with sickle cell disease: is it accurate enough?. Ann Emerg Med. 1999; 34(1):64–69. 20. Smith K, Zhao H, Hodinka RL, et al. Epidemiology of human parvovirus B19 in children with sickle cell disease. Blood. 2004; 103(2):422–427. 21. Gil K, Carson J, Porter L, Ready J, Valrie C, et al. Daily stress and mood and their association with pain, health-care use, and school activity in adolescents with sickle cell disease. J Pediatr Psychol. 2003; 28(5):363–373. 22. Jacob E, Miaskowski C, Savedra M, Beyer J, Treadwell M, Styles L. Management of vaso-occlusive pain in children with sickle cell disease. J Pediatr Hematol Oncol. 2003; 25(4):307–311.https://revistas.unab.edu.co/index.php/medunab/article/view/2378Maakaron J, Taher A. Sickle Cell Anemia. Medscape article.[Internet].2015.[Updated:Oct15,2015]. Disponible http://emedicine.medscape.com/article/205926-overviewQuintero M, Jiménez A. Anemia De Células Falciformes. Revista Gastrohnup. 2012; 14(2):Sup1:S27-S35AyalaA,GonzálezH,DavidG.Anemiadecélulas falciformes:unarevisión.SaludUninorte.2016; 32(3):513-527Kavanagh P, Sprinz P, Vinci S, Bauchner H, Wang C. Management of Children With Sickle Cell Disease: A Comprehensive Review of th eLiterature.Pediatrics. 2011; 128(6):1552-1574LemanekK,RanalliM,LukensC.Arandomized controlled trial of massage therapy in children with sickle cell disease. J Pediatr Psychol. 2009; 34(10):1091–1096McClellan C, Schatz J, Puffer E, Sanchez C, Stancil M, Roberts C. Use of handheld wireless technology for a home-based sickle cell pain management protocol. J Pediatr Psychol. 2009; 34(5):564–573Nolan V, Zhang Y, Lash T, Sebastiani P, Steinberg M. Association between wind speed and the occurrence of sicklecellacutepainfulepisodes:resultsofa casecrossover study. Br J Haematol. 2008; 143(3):433–8Meier E, Miller J. Sickle cell disease in children. Drugs. 2012; 72(7):895-906Sparkenbaugh E, Pawlinski R. Prothrombotic aspects of sicklecelldisease.JThrombHaemost.2017; 15(7):1307–16CerveraÁ,CelaE.Anemiafalciforme.Manejoen Atención Primaria. Rev Pediatr Aten Primaria. 2007; 9(36):649-68Driscoll M, Hurlet A, Styles L, Mckie V, Files B, et al. Stroke risk in siblings with sickle cell anemia. Blood. 2003; 101(6):2401-2404Yazdanbakhsh K, Shaz B, Hillyer C. Immune regulation of sickle cell alloimmunization. ISBT Science Series. 2017; 12(1):248–253.Disponibleen:https://doi.org/10.1111/ voxs.12296National Heart, Lung, and Blood Institute. Management andtherapyofsicklecelldisease.4ed.Bethesda. [Internet]. 2002. [Revisado el: Oct 15, 2015]. Disponible en: https://www.nhlbi.nih.gov/files/docs/guidelines/sc_mngt.pdAmericanAcademyofPediatrics,Sectionon Hematology/OncologyandCommitteeonGenetics. Health supervision for children with sickle cell disease. Pediatrics. 2002; 109(3):526-35Adams R, McKie V, Hsu L, Files B, Vichinsky E, et al. Prevention of a First Stroke by Transfusions in Children withSickleCellAnemiaandAbnormalResultson Transcranial Doppler Ultrasonography. N Engl J Med. 1998; 339:5-1Yawn B, Buchanan G, Afenyi-Annan A, et al. Management of Sickle Cell Disease: Summary of the 2014 Evidence-Based Report by Expert Panel Members. JAMA. 2014; 312(10):1033-1048.Disponibleen:https://doi.org/ 10.1001/Jama.2014.10517Adams R, Brambilla D, Granger S, Gallagher D, Vichinsky E, et al. Stroke and Conversion To High Risk In Children Screened With Transcranial Doppler Ultrasound During The STOP Study. Blood. 2004; 103(10):3689-3694Vichinsky E, Neumayr L, Earles A, Williams R, Lennette E, et al. Causes and outcomes of the acute chest syndrome insicklecelldisease.NEnglJMed.2000; 342(25):1855–1865Morris C, Vichinsky E, Styles L. Clinician assessment for acute chest syndrome in febrile patients with sickle cell disease: is it accurate enough?. Ann Emerg Med. 1999; 34(1):64–69Smith K, Zhao H, Hodinka RL, et al. Epidemiology of human parvovirus B19 in children with sickle cell disease. Blood. 2004; 103(2):422–427Gil K, Carson J, Porter L, Ready J, Valrie C, et al. Daily stress and mood and their association with pain, health-care use, and school activity in adolescents with sickle cell disease. J Pediatr Psychol. 2003; 28(5):363–373Jacob E, Miaskowski C, Savedra M, Beyer J, Treadwell M, Styles L. Management of vaso-occlusivepainin children with sickle cell disease. J Pediatr Hematol Oncol. 2003; 25(4):307–311http://creativecommons.org/licenses/by-nc-nd/2.5/co/Atribución-NoComercial-SinDerivadas 2.5 Colombiahttp://purl.org/coar/access_right/c_abf2MedUNAB; Vol. 20 Núm. 3 (2018): Diciembre - Marzo de 2018: Educación, Tabaquismo, Accidente Ofídico; 374-382Anemia de células falciformes en pediatría: revisión de la literaturaSickle cell anemia in pediatrics: literature reviewAnemia falciforme em pediatria: Revisão da literaturainfo:eu-repo/semantics/articleArtículohttp://purl.org/coar/resource_type/c_6501http://purl.org/coar/resource_type/c_2df8fbb1http://purl.org/redcol/resource_type/ARThttp://purl.org/coar/version/c_970fb48d4fbd8a85Anemia, HemolyticAnemia, Sickle CellHemoglobin, SicklePediatricsHemoglobin SC DiseaseCiencias médicasCiencias de la saludAnemia hemolíticaAnemia de células falciformesHemoglobina falciformePediatríaEnfermedad de la hemoglobina SCORIGINAL2018_Anemia_de_células_falciformes_en_pediatría.pdf2018_Anemia_de_células_falciformes_en_pediatría.pdfArticuloapplication/pdf1685407https://repository.unab.edu.co/bitstream/20.500.12749/9962/1/2018_Anemia_de_c%c3%a9lulas_falciformes_en_pediatr%c3%ada.pdf08a3ba7af4183115dcccb5ec13b4bd2eMD51open accessTHUMBNAIL2018_Anemia_de_células_falciformes_en_pediatría.pdf.jpg2018_Anemia_de_células_falciformes_en_pediatría.pdf.jpgIM Thumbnailimage/jpeg8972https://repository.unab.edu.co/bitstream/20.500.12749/9962/2/2018_Anemia_de_c%c3%a9lulas_falciformes_en_pediatr%c3%ada.pdf.jpg3d16d223c2431d65fee752da3780ab8dMD52open access20.500.12749/9962oai:repository.unab.edu.co:20.500.12749/99622024-04-15 16:28:12.636open accessRepositorio Institucional \| Universidad Autónoma de Bucaramanga - UNABrepositorio@unab.edu.co

Anemia de células falciformes en pediatría: revisión de la literatura

Publicaciones similares